FDA Approves Drug for Autism Irritability
Posted on: Friday, 13 October 2006, 09:03 CDT
The U.S. Food and Drug Administration approved Risperdal to treat irritability in autistic children and adolescents.
This is the first time the FDA approved a drug to treat behavior-related problems associated with autism in children, the FDA said in a news release. The drug can be used to treat aggression, deliberate self-injury and temper tantrums, all of which are classified under irritability.
Risperdal is an anti-psychotic drug used to treat adults with schizophrenia, the FDA said. In 2003, it was also approved as a short-term treatment for adults with acute manic episodes or extreme mood swings.
Risperdal is manufactured by Janssen Pharmaceutica N.V. in Beerse, Belgium.
Source: United Press International
Related Articles
- European Commission and United States Food and Drug Administration (FDA) Both Approve New Options for Patients With Certain Primary Brain Tumors
- Supplemental New Drug Application for RISPERDAL(R) CONSTA(R) Submitted to the FDA for the Treatment of Frequently Relapsing Bipolar Disorder
- Noven's Licensed CNS Drug Receives FDA's Tentative Approval
- TYZEKA(TM) (Telbivudine) Approved By U.S. Food and Drug Administration (FDA) As a New Treatment for Patients With Chronic Hepatitis B
- Valeant Parkinson's Drug Gets FDA Approval
- FDA Approves Pfizer Drug Treating Stomach, Kidney Cancer
- FDA Panel Approves OSI Pharmaceuticals' Anti-Cancer Drug Tarceva
- Orthometrix, Inc. Announces FDA Market Approval for Its New Orbasone(TM) ESWT Pain Relief System to Treat Foot Pain
- U.S. Food and Drug Administration (FDA) Approves BARACLUDE(TM) (Entecavir) for Treatment of Chronic Hepatitis B
- FDA Grants Approval for New Oral Solution of LEVAQUIN(R)
 |
 |
User Comments (0)
RSS Feeds